DarioHealth Reports Second Quarter 2025 Financial and Operating Results

About this update from Dariohealth Corp.

[{"type":"list","items":[{"val":[{"type":"text","content":"Second quarter 2025 revenue was $5.4 million, compared to $6.3 million in the second quarter of 2024, and $6.8 million in the first quarter of 2025 - The Company believes that strong client momentum and strategic wins will offset decrease in revenues ","length":250,"tagName":"p"}]},{"val":[{"type":"text","content":"Approximately $5 million new committed annual recurring revenues ("CARR"); Plus $53 million pipeline of commercial opportunities, over $5 million of which is in final stages toward CARR - On track to secure total of 40 new clients by the end of 2025 ","length":260,"tagName":"p"}]},{"val":[{"type":"text","content":"Two new health plan clients are expected to represent multi-million-dollar opportunities for Dario over time, including a full-suite national health plan scheduled to launch in the second half of 2025","length":200,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross margin increased to 55% compared to 44% in the second quarter of 2024","length":75,"tagName":"p"}]},{"val":[{"type":"text","content":"The core Business-to-Business-to-Consumer ("B2B2C") has been operating at approximately 80% gross margins on a non-GAAP basis since the first quarter of 2024","length":167,"tagName":"p"}]},{"val":[{"type":"text","content":"Operating loss in the second quarter of 2025 narrowed by 43% compared to the second quarter of 2024 ","length":99,"tagName":"p"}]},{"val":[{"type":"text","content":"Operating expenses for the second quarter of 2025 decreased by $6.8 million, or 36%, from the second quarter of 2024 with additional efficiencies anticipated through ongoing AI-driven process optimization","length":204,"tagName":"p"}]},{"val":[{"type":"text","content":"Dario will host an investor conference call and webcast at 8:30 a.m. ET today","length":77,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":1332,"olType":false},{"type":"text","content":"NEW YORK, Aug. 12, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced financial results for the second quarter ended June 30, 2025, along with strategic and commercial updates. While the Company continues to make significant progress across key strategic areas, the second quarter of 2025 revenue came in bel...

More updates from Dariohealth Corp.